BRPI0917518A2 - formulações de canfosfamida e suas preparações - Google Patents

formulações de canfosfamida e suas preparações

Info

Publication number
BRPI0917518A2
BRPI0917518A2 BRPI0917518A BRPI0917518A BRPI0917518A2 BR PI0917518 A2 BRPI0917518 A2 BR PI0917518A2 BR PI0917518 A BRPI0917518 A BR PI0917518A BR PI0917518 A BRPI0917518 A BR PI0917518A BR PI0917518 A2 BRPI0917518 A2 BR PI0917518A2
Authority
BR
Brazil
Prior art keywords
camphosphamide
formulations
preparations therefor
therefor
preparations
Prior art date
Application number
BRPI0917518A
Other languages
English (en)
Inventor
Betsy R Hughes
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Publication of BRPI0917518A2 publication Critical patent/BRPI0917518A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0917518A 2008-08-28 2009-08-04 formulações de canfosfamida e suas preparações BRPI0917518A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9258008P 2008-08-28 2008-08-28
PCT/US2009/052694 WO2010025011A1 (en) 2008-08-28 2009-08-04 Formulations of canfosfamide and their preparation

Publications (1)

Publication Number Publication Date
BRPI0917518A2 true BRPI0917518A2 (pt) 2015-11-17

Family

ID=41168726

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917518A BRPI0917518A2 (pt) 2008-08-28 2009-08-04 formulações de canfosfamida e suas preparações

Country Status (17)

Country Link
US (2) US20100056825A1 (pt)
EP (1) EP2328591A1 (pt)
JP (1) JP2012501331A (pt)
KR (1) KR20110060898A (pt)
CN (1) CN102123714A (pt)
AR (1) AR073074A1 (pt)
AU (1) AU2009286010A1 (pt)
BR (1) BRPI0917518A2 (pt)
CA (1) CA2733548A1 (pt)
CL (1) CL2011000439A1 (pt)
IL (1) IL211039A0 (pt)
MX (1) MX2011001867A (pt)
NZ (1) NZ591213A (pt)
RU (1) RU2011109921A (pt)
TW (1) TW201008599A (pt)
WO (1) WO2010025011A1 (pt)
ZA (1) ZA201101214B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100056825A1 (en) 2008-08-28 2010-03-04 Telik, Inc. Formulations of canfosfamide and their preparation
US8324426B2 (en) 2008-08-28 2012-12-04 Telik, Inc. Formulations of canfosfamide and their preparation
WO2012115655A1 (en) * 2011-02-25 2012-08-30 Telik, Inc. Formulations of canfosfamide and their preparation
JP6676779B2 (ja) * 2017-05-03 2020-04-08 ファミアナ・ヘルス・サイエンス・インク 癌及び前癌病変に対する治療剤、治療方法、及び治療薬剤製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931441A (en) 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
US6403098B1 (en) 1996-09-26 2002-06-11 Merck & Co., Inc. Rotavirus vaccine formulations
WO2000056286A1 (en) 1999-03-19 2000-09-28 Ranbaxy Laboratories Limited Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
ATE533509T1 (de) 2003-08-08 2011-12-15 Ono Pharmaceutical Co Herzverlangsamender arzneistoff mit beta-blockern mit kurzzeitwirkung als wirkstoff
US8198247B2 (en) * 2004-12-21 2012-06-12 Telik, Inc. Process for and intermediates in the preparation of canfosfamide and its salts
CN101291658B (zh) 2005-08-31 2014-04-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
US20100056825A1 (en) 2008-08-28 2010-03-04 Telik, Inc. Formulations of canfosfamide and their preparation
US8324426B2 (en) 2008-08-28 2012-12-04 Telik, Inc. Formulations of canfosfamide and their preparation

Also Published As

Publication number Publication date
IL211039A0 (en) 2011-04-28
US20100056825A1 (en) 2010-03-04
JP2012501331A (ja) 2012-01-19
CL2011000439A1 (es) 2011-07-15
MX2011001867A (es) 2011-04-07
US8481781B2 (en) 2013-07-09
EP2328591A1 (en) 2011-06-08
KR20110060898A (ko) 2011-06-08
ZA201101214B (en) 2013-07-31
TW201008599A (en) 2010-03-01
WO2010025011A8 (en) 2010-09-30
NZ591213A (en) 2012-11-30
RU2011109921A (ru) 2012-10-10
WO2010025011A1 (en) 2010-03-04
US20110224175A1 (en) 2011-09-15
AR073074A1 (es) 2010-10-13
AU2009286010A1 (en) 2010-03-04
CN102123714A (zh) 2011-07-13
CA2733548A1 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
BRPI0914155A2 (pt) preparações de xampu
BRPI0914152A2 (pt) preparações de xampu
DK2068886T3 (da) Lipidholdige præparater
BRPI0912213A2 (pt) preparação cosmética
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BRPI0814252A2 (pt) Formulações de anticorpo
PT2889310T (pt) Formulações de anticorpo
BRPI0908785A2 (pt) Formulações herbicida
BRPI0919552A2 (pt) Formulações de glifosato contendo surfactantes e amidoalquilamina
HUE037163T2 (hu) Hemoglobin készítmények
BRPI0820381A2 (pt) Formulações farmacêuticas
HRP20181347T1 (hr) Formulacije dvoslojne tablete
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
DK2066354T3 (da) Norovirus vaccine formuleringer
BRPI0814188A2 (pt) Formulações
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0822221A2 (pt) Composições aquosas e estáveis de ciclosporina
PT2356462T (pt) Composições e métodos anti-cxcr1
BRPI0921947A2 (pt) formulações de proteína terapêutica
HUE036071T2 (hu) Macitentánt tartalmazó terápiás készítmények
BR112012005389A2 (pt) preparações pesticidas
DK4218797T5 (da) Stabiliseret væske og frysetørrede adamts13-formuleringer
DE112008003934A5 (de) Kosmetikmaske
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
BRPI0908455A2 (pt) formulações de flibanserina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2370 DE 07-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.